FDA approves melphalan as a liver-directed treatment for uveal melanoma

[FDA]

On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System) containing melphalan (HEPZATO, Delcath Systems, Inc.)


Baca selengkapnya di : http://www.fda.gov...